JPRN-UMIN000024146已完成未知
Can fecal calprotectin be a predictive marker for refractoriness in patients with ulcerative colitis ? - Fecal calprotectin for refractory ulcerative colitis
Showa University, School of Medicine0 个研究点目标入组 100 人开始时间: 2016年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are willing to recieve topical therapies, not willing to samlple feces and regular users of non-steroidal antiinflammatory drugs.
研究者
相似试验
已完成
不适用
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54
进行中（未招募）
不适用
Does measurement of fecal calprotectin levels help distinguish various colitis?Diseases of the digestive systemKCT0003598Eulji University Hospital30
招募中
不适用
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot study10017966colitisNL-OMON42995ederlands Kanker Instituut50
尚未招募
不适用
Fecal calprotectin as a predictive factor of relapse in patients with ulcerative colitis treated with tacrolimus : A prospective studyJPRN-UMIN000014714Shimane University Hospital50
招募中
不适用
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50